Cargando…

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children

BACKGROUND: In the past few years, Mycoplasma pneumoniae (Shi et al. Lancet 390:946–958, 2017) infection has been reported more in China. However, there are few studies on the clinical characteristics and prognosis of necrotizing pneumonia (NP) (Griffiths et al. Nature 583:615–619, 2020) caused by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Beilei, Zhang, Weili, Gu, Wenjing, Zhang, Xinxing, Wang, Meijuan, Huang, Li, Zhu, Canhong, Yan, Yongdong, Ji, Wei, Ni, Huiping, Chen, Zhengrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356421/
https://www.ncbi.nlm.nih.gov/pubmed/34376156
http://dx.doi.org/10.1186/s12879-021-06469-x
_version_ 1783736941493092352
author Yang, Beilei
Zhang, Weili
Gu, Wenjing
Zhang, Xinxing
Wang, Meijuan
Huang, Li
Zhu, Canhong
Yan, Yongdong
Ji, Wei
Ni, Huiping
Chen, Zhengrong
author_facet Yang, Beilei
Zhang, Weili
Gu, Wenjing
Zhang, Xinxing
Wang, Meijuan
Huang, Li
Zhu, Canhong
Yan, Yongdong
Ji, Wei
Ni, Huiping
Chen, Zhengrong
author_sort Yang, Beilei
collection PubMed
description BACKGROUND: In the past few years, Mycoplasma pneumoniae (Shi et al. Lancet 390:946–958, 2017) infection has been reported more in China. However, there are few studies on the clinical characteristics and prognosis of necrotizing pneumonia (NP) (Griffiths et al. Nature 583:615–619, 2020) caused by different pathogens. METHODS: A retrospective analysis was performed, including 31 children with a clinical diagnosis of NP in the hospital from January 1, 2013 to January 31, 2020. A total of 11 children with MPNP were included in the observation group and the other 20 children with other pathogens were included in the control group. The clinical manifestations, laboratory data, imaging findings, treatments and outcomes were analyzed. RESULTS: The proportion of dyspnea cases was significantly higher in the non-Mycoplasma pneumoniae necrotizing pneumonia (N-MPNP) group than that in the Mycoplasma pneumoniae necrotizing pneumonia (MPNP) group (P = 0.02).The LDH level of all patients in the MPNP group was higher than the normal value, with a median value of 805.0 U/L, which was significantly higher than those in the N-MPNP group (414.0 [299.9–540.6] U/L; Z =  − 2.518; P = 0.012). The white blood cells (WBCs) count of the N-MPNP group was 17.8 (11.1–21.7) × 10(9)/L, which was significantly higher than that of the MPNP group (10.2 [6.3–14.1] × 10(9)/L; P < 0.05). The mean time of pulmonary necrosis in the MPNP group was 20.9 ± 6.9 days, which was higher than that of the N-MPNP group (16.8 ± 6.1 days; t = 3.101; P = 0.004). The incidence of pleural effusion in the N-MPNP group (19 patients, 95%) was significantly higher than that in the MPNP group (six patients, 54.55%) (P = 0.013). Among them, two patients received bronchoscopy lavage at a maximum four times, and the cases of plastic bronchitis were seen only in the MPNP group (3 cases; P = 0.037).The length of stay was 18 (10–22) days in the MPNP group and 23.5 (13.5–47) days in the N-MPNP group and no significant difference was observed between the two groups (Z =  − 1.923, P =  − 0.055). CONCLUSIONS: 1. MP infection is the most common infection in children with NP in the Suzhou area. There is no gender and age difference between MPNP and N-MPNP, but the bacterial infection was mainly observed in the N-MPNP group. 2. Children in the N-MPNP group have more severe clinical symptoms, were more prone to shortness of breath, had a longer hospital stay, and had earlier imaging manifestations of necrosis, whereas children in the MPNP group were more likely to have plastic bronchitis. The level of WBC and LDH and the nature of pleural effusion can be used to identify MPNP and N-MPNP to some extent. 3. The prognosis of MPNP was better than that of N-MPNP. There were no death cases. Pleural thickening, pulmonary fibrosis, and bronchiectasis were the most common sequelae. Compared with N-MPNP, the recovery time of lung imaging in MPNP was shorter.
format Online
Article
Text
id pubmed-8356421
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83564212021-08-11 Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children Yang, Beilei Zhang, Weili Gu, Wenjing Zhang, Xinxing Wang, Meijuan Huang, Li Zhu, Canhong Yan, Yongdong Ji, Wei Ni, Huiping Chen, Zhengrong BMC Infect Dis Research BACKGROUND: In the past few years, Mycoplasma pneumoniae (Shi et al. Lancet 390:946–958, 2017) infection has been reported more in China. However, there are few studies on the clinical characteristics and prognosis of necrotizing pneumonia (NP) (Griffiths et al. Nature 583:615–619, 2020) caused by different pathogens. METHODS: A retrospective analysis was performed, including 31 children with a clinical diagnosis of NP in the hospital from January 1, 2013 to January 31, 2020. A total of 11 children with MPNP were included in the observation group and the other 20 children with other pathogens were included in the control group. The clinical manifestations, laboratory data, imaging findings, treatments and outcomes were analyzed. RESULTS: The proportion of dyspnea cases was significantly higher in the non-Mycoplasma pneumoniae necrotizing pneumonia (N-MPNP) group than that in the Mycoplasma pneumoniae necrotizing pneumonia (MPNP) group (P = 0.02).The LDH level of all patients in the MPNP group was higher than the normal value, with a median value of 805.0 U/L, which was significantly higher than those in the N-MPNP group (414.0 [299.9–540.6] U/L; Z =  − 2.518; P = 0.012). The white blood cells (WBCs) count of the N-MPNP group was 17.8 (11.1–21.7) × 10(9)/L, which was significantly higher than that of the MPNP group (10.2 [6.3–14.1] × 10(9)/L; P < 0.05). The mean time of pulmonary necrosis in the MPNP group was 20.9 ± 6.9 days, which was higher than that of the N-MPNP group (16.8 ± 6.1 days; t = 3.101; P = 0.004). The incidence of pleural effusion in the N-MPNP group (19 patients, 95%) was significantly higher than that in the MPNP group (six patients, 54.55%) (P = 0.013). Among them, two patients received bronchoscopy lavage at a maximum four times, and the cases of plastic bronchitis were seen only in the MPNP group (3 cases; P = 0.037).The length of stay was 18 (10–22) days in the MPNP group and 23.5 (13.5–47) days in the N-MPNP group and no significant difference was observed between the two groups (Z =  − 1.923, P =  − 0.055). CONCLUSIONS: 1. MP infection is the most common infection in children with NP in the Suzhou area. There is no gender and age difference between MPNP and N-MPNP, but the bacterial infection was mainly observed in the N-MPNP group. 2. Children in the N-MPNP group have more severe clinical symptoms, were more prone to shortness of breath, had a longer hospital stay, and had earlier imaging manifestations of necrosis, whereas children in the MPNP group were more likely to have plastic bronchitis. The level of WBC and LDH and the nature of pleural effusion can be used to identify MPNP and N-MPNP to some extent. 3. The prognosis of MPNP was better than that of N-MPNP. There were no death cases. Pleural thickening, pulmonary fibrosis, and bronchiectasis were the most common sequelae. Compared with N-MPNP, the recovery time of lung imaging in MPNP was shorter. BioMed Central 2021-08-10 /pmc/articles/PMC8356421/ /pubmed/34376156 http://dx.doi.org/10.1186/s12879-021-06469-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Beilei
Zhang, Weili
Gu, Wenjing
Zhang, Xinxing
Wang, Meijuan
Huang, Li
Zhu, Canhong
Yan, Yongdong
Ji, Wei
Ni, Huiping
Chen, Zhengrong
Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title_full Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title_fullStr Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title_full_unstemmed Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title_short Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
title_sort differences of clinical features and prognosis between mycoplasma pneumoniae necrotizing pneumonia and non-mycoplasma pneumoniae necrotizing pneumonia in children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356421/
https://www.ncbi.nlm.nih.gov/pubmed/34376156
http://dx.doi.org/10.1186/s12879-021-06469-x
work_keys_str_mv AT yangbeilei differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT zhangweili differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT guwenjing differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT zhangxinxing differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT wangmeijuan differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT huangli differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT zhucanhong differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT yanyongdong differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT jiwei differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT nihuiping differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren
AT chenzhengrong differencesofclinicalfeaturesandprognosisbetweenmycoplasmapneumoniaenecrotizingpneumoniaandnonmycoplasmapneumoniaenecrotizingpneumoniainchildren